Materialise NV (MTLS) Stock
Materialise stock price chart
MTLS stock quote & key statistics
Materialise annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $257.1M | $7.4M | $0.16 |
| FY2024 | $266.8M | $13.4M | $0.23 |
| FY2023 | $256.1M | $6.7M | $0.11 |
| FY2022 | $232.0M | -$2.1M | -$0.04 |
| FY2021 | $205.4M | $13.2M | $0.24 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Materialise NV
Materialise NV is a pioneering company specializing in additive manufacturing and medical software, as well as providing 3D printing services across the Americas, Europe, Africa, and the Asia-Pacific region. The company operates through three main segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, each dedicated to leveraging advanced technology to enhance various industries.
The Materialise Software segment offers cutting-edge software solutions that enhance the functionality of 3D printers and streamline 3D printing operations. This software bridges the gap between different types of 3D printers and a variety of software applications and capturing technologies, such as CAD/CAM packages and 3D scanners. The segment serves a wide range of clients, including 3D printing machine manufacturers, automotive and aerospace production companies, consumer goods manufacturers, and hearing aid producers. Additionally, 3D printing service bureaus benefit from its comprehensive sales force, website, and third-party distributor network.
In the Materialise Medical segment, the company provides innovative medical software that facilitates medical-image based analysis and engineering. This software is crucial for the patient-specific design of surgical devices and implants, serving medical device companies, hospitals, universities, research institutes, and industrial companies. The segment reaches its customers through a direct sales force, an extensive website, and partnerships with picture archiving and communication system (PACS) providers, enhancing the precision and customization of medical treatments.
The Materialise Manufacturing segment offers a broad spectrum of 3D printing services, including design and engineering services, rapid prototyping, and the additive manufacturing of production parts. These services cater to industrial and commercial customers, fostering innovation and efficiency in product development and manufacturing processes. Headquartered in Leuven, Belgium, and incorporated in 1990, Materialise NV collaborates with notable companies such as Zimmer Biomet Holdings, Inc., Encore Medical, L.P., DePuy Synthes Companies of Johnson & Johnson, Limacorporate Spa, Mathys AG, Corin Ltd, Medtronic Inc., and Abbott Laboratories Inc., highlighting its significant impact and reach in the industry.
Materialise stock FAQ
What is the Materialise stock ticker symbol?
Materialise NV trades on the NASDAQ under the ticker symbol MTLS.
What sector and industry is Materialise in?
Materialise NV is classified in the Technology sector, Software - Application industry.
How many employees does Materialise have?
Materialise NV has about 2,556 full-time employees.
What were Materialise's revenue and earnings last fiscal year?
Materialise reported revenue of $257.1M and net income of $7.4M in fiscal 2025, with earnings per share of $0.16. Revenue declined 3.6% from the prior year.
When did Materialise go public?
Materialise stock began trading on June 25, 2014.
Software - Application stocks
All Technology stocks →- ADBEAdobe
- ADPADP
- ADSKAutodesk
- CDNSCadence
- CRMSalesforce
- DBDDiebold Nixdorf
- DDOGDatadog
- DOCUDocuSign
- HUBSHubSpot
- INTUIntuit
- LYFTLyft
- NATLNCR Atleos
- NOWServiceNow
- PAYXPaychex
- PTCPTC
- ROPRoper
- SHOPShopify
- SNOWSnowflake
- SSNCSS&C Technologies
- TEAMAtlassian
- UBERUber
- UPBDUpbound
- WDAYWorkday
- ZMZoom Video Communications